Latest News

January 22, 2018

Shutdown Winds Down: Short ‘Lapse Period’ Likely Means Few Disruptions At US FDA

January 22, 2018 / 0 Comments 0 Comments
The Pink Sheet –  This article looks at the impact of the recent government shutdown on FDA and includes Catalyst’s perspectives the challenges involved; Catalyst President Nancy Myers notes that timelines… read more →
January 17, 2018

How a government shutdown could affect drug safety, flu response, and more

January 17, 2018 / 0 Comments 0 Comments
In this article, Catalyst’s Jill Hartzler Warner provides context for a potential future government shutdown, based on her experience at FDA. The article explores the potential impact of a federal… read more →
January 10, 2018

New FDA Leadership Changes Priorities But Doesn’t Change Administration Regulations, Panel Discussion Says

January 10, 2018 / 0 Comments 0 Comments
Biotech Investing News— Biotech Investing News reporters this week covered a panel featuring Catalyst’s President, Nancy Bradish Myers. In the panel, which took place on the first day of the JP… read more →

View News Archive

Latest Events

January 3, 2018

The Impact of New FDA Leadership: Catalyst to Speak at Biotech Showcase Conference

January 3, 2018 / 0 Comments 0 Comments
Come and join us on Jan. 8 as Catalyst President Nancy Bradish Myers speaks as part of a panel on “The impact of new leadership and new initiatives at FDA.”… read more →
December 4, 2017

Digital Medicine: Catalyst to Speak at Digital Medicine & MedTech Showcase

December 4, 2017 / 0 Comments 0 Comments
Join us on Jan. 9 as Catalyst President Nancy Bradish Myers speaks as part of a panel entitled “Once the train has left the station, is it possible to regulate?”… read more →
August 23, 2017

The Changing Regulatory Landscape Under Gottlieb and Trump: Catalyst Featured as Part of Expert Panel Webinar Series

August 23, 2017 / 0 Comments 0 Comments
Catalyst VP-Regulatory Policy and ex-FDAer Jill Hartzler Warner, JD, will analyze the changing regulatory environment for biopharma and device companies as part of an FDANews expert panel series this Fall.… read more →

View Events Archive

Back to Top
UA-64850428-1